D. Jones

WAY100135: a novel, selective antagonist at presynaptic and postsynaptic 5-HT1A receptors.

Y. Reilly, J. Haskins, G. Dover, 1993, European journal of pharmacology.

A pharmacological profile of the selective silent 5-HT1A receptor antagonist, WAY-100635.

I A Cliffe, Y. Reilly, G. Dover, 1995, European journal of pharmacology.

Lecozotan (SRA-333): A Selective Serotonin 1A Receptor Antagonist That Enhances the Stimulated Release of Glutamate and Acetylcholine in the Hippocampus and Possesses Cognitive-Enhancing Properties

J. Barrett, K. Marquis, J. Buccafusco, 2005, Journal of Pharmacology and Experimental Therapeutics.

Quantifying the 5-HT1A agonist action of buspirone in man

M. Kendall, A. Sharma, C. Thompson, 2001, Psychopharmacology.

311C90, A new central and peripherally acting 5-HT1D receptor agonist in the acute oral treatment of migraine

M. Ferrari, W. Visser, K. Klein, 1996, Neurology.